265 related articles for article (PubMed ID: 23907667)
1. BRSK2 is a valosin-containing protein (VCP)-interacting protein that affects VCP functioning in endoplasmic reticulum-associated degradation.
Wang Y; Wan B; Zhou J; Li R; Yu L
Biotechnol Lett; 2013 Dec; 35(12):1983-9. PubMed ID: 23907667
[TBL] [Abstract][Full Text] [Related]
2. Interaction between salt-inducible kinase 2 (SIK2) and p97/valosin-containing protein (VCP) regulates endoplasmic reticulum (ER)-associated protein degradation in mammalian cells.
Yang FC; Lin YH; Chen WH; Huang JY; Chang HY; Su SH; Wang HT; Chiang CY; Hsu PH; Tsai MD; Tan BC; Lee SC
J Biol Chem; 2013 Nov; 288(47):33861-33872. PubMed ID: 24129571
[TBL] [Abstract][Full Text] [Related]
3. AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation.
Zhong X; Shen Y; Ballar P; Apostolou A; Agami R; Fang S
J Biol Chem; 2004 Oct; 279(44):45676-84. PubMed ID: 15331598
[TBL] [Abstract][Full Text] [Related]
4. Regulation of ER-associated degradation via p97/VCP-interacting motif.
Ballar P; Fang S
Biochem Soc Trans; 2008 Oct; 36(Pt 5):818-22. PubMed ID: 18793143
[TBL] [Abstract][Full Text] [Related]
5. The role of a novel p97/valosin-containing protein-interacting motif of gp78 in endoplasmic reticulum-associated degradation.
Ballar P; Shen Y; Yang H; Fang S
J Biol Chem; 2006 Nov; 281(46):35359-68. PubMed ID: 16987818
[TBL] [Abstract][Full Text] [Related]
6. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
Weihl CC; Dalal S; Pestronk A; Hanson PI
Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
[TBL] [Abstract][Full Text] [Related]
7. Selenoprotein S-dependent Selenoprotein K Binding to p97(VCP) Protein Is Essential for Endoplasmic Reticulum-associated Degradation.
Lee JH; Park KJ; Jang JK; Jeon YH; Ko KY; Kwon JH; Lee SR; Kim IY
J Biol Chem; 2015 Dec; 290(50):29941-52. PubMed ID: 26504085
[TBL] [Abstract][Full Text] [Related]
8. Identification of SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degradation.
Ballar P; Zhong Y; Nagahama M; Tagaya M; Shen Y; Fang S
J Biol Chem; 2007 Nov; 282(47):33908-14. PubMed ID: 17872946
[TBL] [Abstract][Full Text] [Related]
9. Central pore residues mediate the p97/VCP activity required for ERAD.
DeLaBarre B; Christianson JC; Kopito RR; Brunger AT
Mol Cell; 2006 May; 22(4):451-62. PubMed ID: 16713576
[TBL] [Abstract][Full Text] [Related]
10. Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells.
Wójcik C; Rowicka M; Kudlicki A; Nowis D; McConnell E; Kujawa M; DeMartino GN
Mol Biol Cell; 2006 Nov; 17(11):4606-18. PubMed ID: 16914519
[TBL] [Abstract][Full Text] [Related]
11. Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates.
Zhong X; Pittman RN
Hum Mol Genet; 2006 Aug; 15(16):2409-20. PubMed ID: 16822850
[TBL] [Abstract][Full Text] [Related]
12. UBXD1 is a VCP-interacting protein that is involved in ER-associated degradation.
Nagahama M; Ohnishi M; Kawate Y; Matsui T; Miyake H; Yuasa K; Tani K; Tagaya M; Tsuji A
Biochem Biophys Res Commun; 2009 May; 382(2):303-8. PubMed ID: 19275885
[TBL] [Abstract][Full Text] [Related]
13. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
Liu S; Fu QS; Zhao J; Hu HY
Biochim Biophys Acta; 2013 Dec; 1834(12):2672-8. PubMed ID: 24100225
[TBL] [Abstract][Full Text] [Related]
14. Different p97/VCP complexes function in retrotranslocation step of mammalian ER-associated degradation (ERAD).
Ballar P; Pabuccuoglu A; Kose FA
Int J Biochem Cell Biol; 2011 Apr; 43(4):613-21. PubMed ID: 21199683
[TBL] [Abstract][Full Text] [Related]
15. The VCP/p97 and YOD1 Proteins Have Different Substrate-dependent Activities in Endoplasmic Reticulum-associated Degradation (ERAD).
Sasset L; Petris G; Cesaratto F; Burrone OR
J Biol Chem; 2015 Nov; 290(47):28175-28188. PubMed ID: 26463207
[TBL] [Abstract][Full Text] [Related]
16. Functional ATPase activity of p97/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells.
Kobayashi T; Tanaka K; Inoue K; Kakizuka A
J Biol Chem; 2002 Dec; 277(49):47358-65. PubMed ID: 12351637
[TBL] [Abstract][Full Text] [Related]
17. Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells.
Nishimura N; Radwan MO; Amano M; Endo S; Fujii E; Hayashi H; Ueno S; Ueno N; Tatetsu H; Hata H; Okamoto Y; Otsuka M; Mitsuya H; Matsuoka M; Okuno Y
Cancer Sci; 2019 Oct; 110(10):3275-3287. PubMed ID: 31368616
[TBL] [Abstract][Full Text] [Related]
18. Destabilization of the VCP-Ufd1-Npl4 complex is associated with decreased levels of ERAD substrates.
Nowis D; McConnell E; Wójcik C
Exp Cell Res; 2006 Sep; 312(15):2921-32. PubMed ID: 16822501
[TBL] [Abstract][Full Text] [Related]
19. Sequential actions of the AAA-ATPase valosin-containing protein (VCP)/p97 and the proteasome 19 S regulatory particle in sterol-accelerated, endoplasmic reticulum (ER)-associated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Morris LL; Hartman IZ; Jun DJ; Seemann J; DeBose-Boyd RA
J Biol Chem; 2014 Jul; 289(27):19053-66. PubMed ID: 24860107
[TBL] [Abstract][Full Text] [Related]
20. Pro178 and Pro183 of selenoprotein S are essential residues for interaction with p97(VCP) during endoplasmic reticulum-associated degradation.
Lee JH; Kwon JH; Jeon YH; Ko KY; Lee SR; Kim IY
J Biol Chem; 2014 May; 289(20):13758-68. PubMed ID: 24700463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
